comparemela.com

Latest Breaking News On - Senate majority leader mitch mcconnellr kentucky - Page 8 : comparemela.com

Bay Area Reporter :: FDA authorizes 2nd COVID-19 vaccine

The federal Food and Drug Administration has granted emergency use authorization for a second COVID-19 vaccine, developed by the Cambridge-based biotechnology company Moderna and the National Institutes of Health, for people age 18 and up. The second green light came December 18, as the first vaccine from Pfizer and BioNTech, approved just over a week ago, is rolling out across the country. Health care workers ranging from custodial staff to doctors began receiving vaccinations at UCSF and Zuckerberg San Francisco General Hospital. More are expected to begin receiving the Moderna vaccine starting this week. The Moderna vaccine was developed with support from the federal government s Operation Warp Speed, and it will be distributed to Americans free of charge.

Presidential election renews calls to abolish Electoral College

Presidential election renews calls to abolish Electoral College
newsday.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newsday.com Daily Mail and Mail on Sunday newspapers.

Malliotakis joins call for congressional investigation into election

Malliotakis joins call for congressional investigation into election Updated Dec 17, 2020; Posted Dec 17, 2020 Congresswoman-elect Nicole Malliotakis joined 25 of her fellow incoming Republican members of Congress in calling for a congressional investigation into the 2020 election. In this file photo, Malliotakis gives a victory speech following the election held Tuesday, Nov. 3, 2020. (Staten Island Advance)Alexandra Salmieri Facebook Share STATEN ISLAND, N.Y. Congresswoman-elect Nicole Malliotakis joined 25 of her fellow incoming Republican members of Congress in a letter Tuesday calling for a congressional investigation into the 2020 election. In the letter to House Speaker Nancy Pelosi (D-California), Malliotakis and the others, who were all elected Nov. 3, wrote that the nation’s election process had “devolved into chaos,” and that their constituents are “deeply concerned” about election integrity.

Trump says he ll make China very unhappy by VETOING defense bill — RT USA News

Follow RT on Though it’s already passed Congress, President Donald Trump says he will veto an annual defense spending bill (NDAA), claiming China “loves” its present form and demanding a harsher crackdown on social media companies. “I will Veto the Defense Bill, which will make China very unhappy,” Trump tweeted on Thursday. “They love it. Must have Section 230 termination, protect our National Monuments and allow for removal of military from far away, and very unappreciative, lands. Thank you!” I will Veto the Defense Bill, which will make China very unhappy. They love it. Must have Section 230 termination, protect our National Monuments and allow for removal of military from far away, and very unappreciative, lands. Thank you! https://t.co/9rI08S5ofO Donald J. Trump (@realDonaldTrump) December 17, 2020

Transatlantic Trade: US and Europe - Week of December 7, 2020

Last week, the United Kingdom (UK) moved forward with its first inoculations of the approved Pfizer/BioNTech COVID-19 vaccine. The United States (US) approved the Pfizer/BioNTech vaccine on Friday, 11 December, and will begin inoculations this coming week. The European Union (EU) continues to stress safety over speed in its vaccine approval process and has yet to follow suit. The UK sealed the deal on a number of Free Trade Agreements, while talks with the EU continue without any significant breakthroughs. Meanwhile, the UK and EU are also preparing for a possible hard exit scenario. This past week, Poland and Hungary reached a compromise with the EU on the custom union’s Budget and Recovery Fund, which will allow funds to flow at the start of the new year. The 116th US Congress, meanwhile, continues negotiations over a new COVID relief package, amid other priorities before adjourning.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.